| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
TRANSLATIONAL PHYSIOLOGY
Departments of 1Medicine and 2Surgery, Dallas Veterans Affairs Medical Center and University of Texas-Southwestern Medical School, Dallas 76235; and 3the Harold C. Simmons Comprehensive Cancer Center and the 4Hamon Center for Therapeutic Oncology Research, University of Texas-Southwestern Medical Center at Dallas, Dallas, Texas 75216
Submitted 1 April 2004 ; accepted in final form 30 June 2004
ABSTRACT
Cyclooxygenase-2 (COX-2) has been linked to neoplastic progression in Barrett's esophagus. Acid exposure has been shown both to activate the MAPK pathways and to increase COX-2 protein expression in Barrett's metaplasia, but it is not known whether these effects are interrelated. We hypothesized that acid-induced activation of the MAPK pathways mediates an increase in COX-2 expression in Barrett's esophagus, and we tested this hypothesis in a Barrett's-associated adenocarcinoma cell line (SEG-1). We exposed SEG-1 cells to acidic or neutral media in the presence and absence of two MAPK inhibitors: U-0126 (an ERK inhibitor) or SB-203580 (a p38 inhibitor). We quantitated COX-2 protein levels using an enzyme immunometric assay and COX-2 mRNA levels using real-time PCR. We also determined how acid affects the activity of the COX-2 promoter and mRNA stability. Compared with SEG-1 cells exposed to neutral media, acid-exposed cells exhibited a 2.8-fold increase in COX-2 mRNA levels within 30 min. Both U-0126 and SB-203580 attenuated the acid-induced increase in COX-2 mRNA. Acid significantly increased COX-2 protein expression and promoter activity, and both of these effects were abolished by treatment with U-0126 and SB-203580. Acid exposure also stabilized COX-2 mRNA levels, an effect that was abolished by U-0126 but not by SB-203580. We conclude that acid increases COX-2 expression through activation of the MAPK pathways. Acid-induced activation of both ERK and p38 causes a significant increase in COX-2 promoter activity, and acid-activated ERK stabilizes COX-2 mRNA. These findings suggest potential mechanisms whereby acid reflux might promote carcinogenesis in Barrett's esophagus.
Barrett's esophagus; messenger ribonucleic acid stability; cell viability
This article has been cited by other articles:
|
|
 |
|
  J. A. Abrams Review: Chemoprevention of esophageal adenocarcinoma Therapeutic Advances in Gastroenterology, July 1, 2008; 1(1): 7 - 18. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Song, S. Guha, K. Liu, N. S Buttar, and R. S Bresalier COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma Gut, November 1, 2007; 56(11): 1512 - 1521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W.P.M. van Baal, S. H. Diks, R. J.A. Wanders, A. M. Rygiel, F. Milano, J. Joore, J. J.G.H.M. Bergman, M. P. Peppelenbosch, and K. K. Krishnadath Comparison of Kinome Profiles of Barrett's Esophagus with Normal Squamous Esophagus and Normal Gastric Cardia Cancer Res., December 15, 2006; 66(24): 11605 - 11612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Feagins, N. Susnow, H. Y. Zhang, S. Pearson, C. Owen, W. F. Schmalstieg, L. S. Terada, S. J. Spechler, R. D. Ramirez, and R. F. Souza Gain of allelic gene expression for IGF-II occurs frequently in Barrett's esophagus Am J Physiol Gastrointest Liver Physiol, May 1, 2006; 290(5): G871 - G875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Oliver III, E. Friday, F. Turturro, A. Lacy, and T. Welbourne Troglitazone's rapid and sustained activation of ERK1/2 induces cellular acidosis in LLC-PK1-F+ cells: physiological responses Am J Physiol Renal Physiol, June 1, 2005; 288(6): F1257 - F1266. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
